Research Article

Safety and Effectiveness of Mist Antiaris, a Herbal Preparation for Treatment of Peripheral Neuropathy

Table 6

Effect of Mist Antiaris on hematological parameters after four weeks of treatment.

ParametersTreatment Group
ControlMist Antiaris
10 mg/kg100 mg/kg200mg/kg

WBC (x103 /µL)14.9 ± 1.0913.1 ± 1.2514.4 ± 0.7714.2 ± 1.12
MPV (f L)7.20 ± 0.097.27 ± 0.087.08 ± 0.077.26 ± 0.07
RBC (x106 /µL)7.79 ± 0.178.15 ± 0.088.14 ±0.208.20 ± 0.17
Hb (g/ d L)15.0 ± 0.1715.0 ± 0.2315.0 ± 0.3215.3 ± 0.18
HCT (%)47.4 ± 0.6347.8 ± 0.8848.3 ± 1.2349.0 ± 0.60
MCV (f L)60.9 ± 1.0458.7 ± 0.7659.4 ± 0.3559.8 ± 0.84
MCH (pg.)19.3 ± 0.4718.4 ± 0.2018.5 ± 0.1318.7 ± 0.29
MCHC (g/ d L)31.7 ± 0.3431.4 ± 0.1531.1 ± 0.1831.3 ± 0.15
PLT (x103/ µL)875 ± 28.8848 ± 80.8912 ± 27.3899 ± 31.2
LYM %73.8 ± 1.6473.0 ± 2.2773.9 ± 3.2676.8 ± 1.52
LYM #10.9 ± 0.639.65 ± 0.9710.2 ± 0.4210.9 ± 0.79
RDW (f L)31.4 ± 0.3230.1 ± 0.5830.6 ± 0.4130.8 ± 0.52

Values are Mean ± SEM, n = 6